• Explore /
  • Poster
  • / Antioxidant stimulation as the adaptation mechanism in patients with metastatic urothelial cancers (MUC) treated with gemcitabine and cisplatin (GC).

Antioxidant stimulation as the adaptation mechanism in patients with metastatic urothelial cancers (MUC) treated with gemcitabine and cisplatin (GC).

Abstract Poster

Authors

Patrik Palacka

Patrik Palacka

2nd Oncology Department, School of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia

Patrik Palacka , Jarmila Kucharska , Michal Mego , Jana Obertova , Jan Rajec , Daniela Svetlovska , Zuzana Sycova-Mila , Anna Mataseje , Jozef Mardiak , Anna Gvozdjakova

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Prostate, Penile, Urethral, and Testicular Cancer, and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancer

Sub Track

Urothelial Carcinoma

Citation

J Clin Oncol 31, 2013 (suppl 6; abstr 281)

DOI

10.1200/jco.2013.31.6_suppl.281

Abstract #

281

Poster Bd #

G10

Abstract Disclosures

Similar Posters

First Author: Jonathan Forrest Anker

First Author: Sarmad Sadeghi

First Author: Sarmad Sadeghi

Poster

2022 ASCO Annual Meeting

Association of DNA damage repair (DDR) mutations (mts) and clinical outcomes in CALGB 90601 (Alliance).

Association of DNA damage repair (DDR) mutations (mts) and clinical outcomes in CALGB 90601 (Alliance).

First Author: Gopa Iyer